News Releases

<< Back
Micromass Wins Highest Honors At The Threshold of the Post-Genomic Era

MILFORD, Mass.--(BUSINESS WIRE)--May 5, 2000--Waters Corporation's (NYSE:WAT) wholly owned subsidiary, Micromass Limited, has been honored twice in the U.K. in the latest Queen's Awards for Enterprise. This year a total of 116 awards were granted in three cateogies: International Trade (77), Innovation (32) and Environmental Achievement (7). Micromass has won two of these prestigious awards, the first for International Trade and the second for Innovation. Mass spectrometry (MS) is now the analytical method of choice for many life-enhancing applications at the threshold of the `post-genomic era'.

A Queen's Award ( is the highest honor that can be bestowed on a United Kingdom business.

The Queen's Awards for International Trade are awarded for outstanding achievement resulting in substantial growth in export sales and commercial success, sustained over not less than three years, to levels which are outstanding for the goods or services concerned. Micromass' award for international trade recognizes the Company's outstanding record of growth and sustained export achievement.

The Queen's Awards for Innovation recognize an outstanding innovation, resulting in a substantial improvement in business performance and commercial success, sustained over not less than two years, to levels which are outstanding for the goods or services concerned. The award for innovation recognizes Micromass' landmark achievement in developing and commercializing the Q-Tof(TM) tandem quadrupole time-of-flight mass spectrometer. Micromass defined this new instrument category with its original Q-Tof(TM), first described in detail at the 44th ASMS Conference in the summer of 1996. Q-Tof(TM)2, the second-generation system, was announced at the 47th ASMS meeting in June 1999.

Micromass' Q-Tof(TM)2 offers greater sensitivity, selectivity and speed than competing LC-MS-MS technologies for structural analysis in the life sciences, e.g. functional genomics, proteomics and drug discovery/development.

The ProteomeWorks(TM) System enhanced with Micromass' Q-Tof(TM) technology is the definitive system for determining the function of proteins in vivo, the major analytical challenge of the post-genomic era.

ProteomeWorks(TM) ( is the product of a global alliance of Micromass and Bio-Rad Laboratories dedicated to furthering proteomics research.

Waters Corporation is a leading supplier of high performance liquid chromatography instrumentation and consumables, and mass spectrometry products for the Life Sciences market, which account for $3 billion in annual revenues of the $16 billion analytical instrument total.

CONTACT: Waters Corporation

             Brian Mazar